Shukla Sanjay's Form 4 filing
aTYR PHARMA INC (ATYR) · filed Nov 13, 2023
- Accession no.
- 0001209191-23-054976
- Filed
- Nov 13, 2023
- Trade date
- Nov 10-13, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $16.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shukla SanjayCIK 0001671026 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2023 | Common Stock | PPurchaseAcquired | +1,422 | $1.14 | +$1,621.08 | 77,595 | Direct | |
| Nov 13, 2023 | Common Stock | PPurchaseAcquired | +13,578 | $1.11 | +$15,071.58 | 91,173 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.